John Goudreau has been named the Michigan State University College of Osteopathic Medicine’s associate dean for research. He also will be the co-director of the DO-PhD training program, a combined degree program where students are trained to become physician scientists.
An associate professor in the departments of neurology and ophthalmology, as well as pharmacology and toxicology, Goudreau is the director of the Movement Disorders Clinic. He also serves as associate department chair for research in neurology and ophthalmology.
An alumnus of the college, Goudreau received his osteopathic doctorate and Ph.D. in neuropharmacology in 1995. He completed a residency in neurology at the Mayo Clinic in 2000, earning the Mayo Brothers Distinguished Fellowship Award. After residency, he completed a movement disorders fellowship at the Mayo Clinic, with a special interest in the genetics of movement disorders and advanced clinical training in the neurophysiology and botulinum toxin treatment of abnormal movements.
Goudreau joined the MSU faculty in July 2001. His research has focused on movement disorders, including Parkinson’s disease, and the evaluation of potential genetic and environmental risk factors for the disease, as well as developing effective neuroprotective and therapeutic drugs.
“John Goudreau has an incredible background and he brings the kind of experience that will allow us to elevate an already outstanding research portfolio,” said Andrea Amalfitano, dean of the College of Osteopathic Medicine. “Because he’s an alumnus of our DO-PhD program, as well as an exemplary leader, I have complete confidence that he’ll do an exemplary job in guiding our physician-scientist training program—the oldest and largest program of its kind.”
He is board certified in neurology and is an active member of the American Academy of Neurology, Movement Disorders Society, American Society for Pharmacology and Experimental Therapeutics, and the American Osteopathic Association.
